Skip to search boxSkip to navigationSkip to main content

Nonessential amino acid metabolism in breast cancer

*Corresponding author for this work
  • Harvard Medical School
Research Output:
Contribution to journal
Review article
Peer-review

Abstract

Interest in studying cancer metabolism has risen in recent years, as it has become evident that the relationship between cancer and metabolic pathways could reveal novel biomarkers and therapeutic targets. Metabolic starvation therapy is particularly promising due to its low toxicity. Nonessential amino acids are promising metabolites for such therapy because they become essential in many tumor cells, including breast cancer cells. This review will focus on four nonessential amino acid metabolism pathways: glutamine–glutamate, serine–glycine, cysteine, and arginine–proline metabolism. Recent studies of these amino acids have revealed metabolic enzymes that have the potential to be effective as cancer therapy targets or biomarkers for response to metabolic starvation therapy. The review will also discuss features of nonessential amino acid metabolism that merit further investigation to determine their relevancy to breast cancer treatment.

Bibliographic Information

Output type

Research Output:
Contribution to journal
Review article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 11-17 (7 pages)

Journal (Volume, Issue Number)

Advances in Biological Regulation (Volume 62)

Publication milestones

  • Published - 01/09/2016

Publication status

Published - 01/09/2016

ISSN

2212-4926

Publication IDs

  • Scopus: 84961807035
  • PubMed: 26838061